CC
CAH icon

ClearArc Capital’s Cardinal Health CAH Stock Holding History

ClearArc Capital’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,507
Closed -$213K – 308
2019
Q3 		$213K Buy
4,507
+46
+1% +$2.1K 0.06% 336
2019
Q2 		$210K Sell
4,461
-525
-11% -$24.2K 0.06% 339
2019
Q1 		$240K Sell
4,986
-126
-2% -$6.31K 0.06% 323
2018
Q4 		$228K Sell
5,112
-2,878
-36% -$150K 0.07% 309
2018
Q3 		$431K Buy
7,990
+22
+0.3% +$1.13K 0.06% 304
2018
Q2 		$389K Sell
7,968
-45
-0.6% -$2.55K 0.05% 317
2018
Q1 		$502K Buy
8,013
+3
+0% +$206 0.08% 264
2017
Q4 		$491K Sell
8,010
-120
-1% -$7.42K 0.07% 277
2017
Q3 		$544K Buy
8,130
+363
+5% +$25.7K 0.08% 246
2017
Q2 		$605K Sell
7,767
-1,105
-12% -$83.4K 0.1% 222
2017
Q1 		$724K Sell
8,872
-41
-0.5% -$3.23K 0.12% 183
2016
Q4 		$641K Sell
8,913
-60
-0.7% -$4.34K 0.12% 195
2016
Q3 		$697K Sell
8,973
-98
-1% -$7.92K 0.13% 178
2016
Q2 		$708K Sell
9,071
-106
-1% -$8.45K 0.14% 166
2016
Q1 		$752K Sell
9,177
-28
-0.3% -$2.28K 0.16% 157
2015
Q4 		$822K Buy
9,205
+92
+1% +$7.81K 0.17% 151
2015
Q3 		$700K Sell
9,113
-232
-2% -$19.4K 0.15% 185
2015
Q2 		$782K Sell
9,345
-11,550
-55% -$1.02M 0.14% 186
2015
Q1 		$1.89M Sell
20,895
-1,885
-8% -$162K 0.39% 68
2014
Q4 		$1.84M Buy
22,780
+13,752
+152% +$1.09M 0.38% 72
2014
Q3 		$676K Buy
9,028
+1,055
+13% +$76.8K 0.15% 177
2014
Q2 		$547K Buy
7,973
+79
+1% +$5.38K 0.13% 203
2014
Q1 		$552K Buy
7,894
+433
+6% +$30.1K 0.14% 193
2013
Q4 		$498K Sell
7,461
-152
-2% -$9.29K 0.13% 194
2013
Q3 		$397K Buy
7,613
+1,053
+16% +$53.5K 0.11% 213
2013
Q2 		$310K Buy
+6,560
New +$300K 0.08% 258

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearArc Capital's CAH Position: Q4 2019 in Review

ClearArc Capital sold out of Cardinal Health (CAH) in Q4 2019, closing a stake of 4,507 shares — an estimated $213K sold.

ClearArc Capital first reported a position in CAH in Q2 2013 and held it in 26 quarters. The position peaked at $1.89M in Q1 2015. 714 funds tracked by Wall St. Rank hold CAH as of Q4 2019.

  • ClearArc Capital reported no remaining Cardinal Health position as of Q4 2019 after selling out during the quarter.
  • ClearArc Capital sold 4,507 Cardinal Health shares in Q4 2019, an estimated $213K.
  • ClearArc Capital first reported a position in Cardinal Health in Q2 2013 and held it in 26 quarters.
  • ClearArc Capital's Cardinal Health position peaked at $1.89M in Q1 2015.
  • 714 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.